[Regulatory] state board actions worth reading if you use a compounder
503B. That is the whole post, but I will justify it.
Everything else people worry about in c/coldchain is downstream of it. Titration speed, early fullness, the endless dose arguments — most of it resolves if you sort 503B out first, and almost nobody does.
I say this having got it wrong for 10 months. My A1c was the thing that eventually made me pay attention, which is a stupid way to learn a lesson that was in the sidebar the whole time.
best — the order this archive was captured in
Mechanistically the bit that matters is 503A. It explains most of the early profile and a decent chunk of the outcome.
Disagree but this is the good kind of wrong — it is specific enough to be checked.
Asked 19 compounders about API source. One told me, one dodged, one said they cannot say. The answer is the signal.
The 503A pharmacy I used lost their shortage list eligibility. Same day, compounding became illegal. Rules are real.
API transparency is the question that separates good compounders from sketchy ones
the 503A/503B distinction is load-bearing, do not blur it
Removed a chain here. The rule is one line long and it is not negotiable.
Edit to your parent would help — the concentration you quoted assumes one scenario and you have written another above it.
API source questions are on-topic and compounders dodging them is newsworthy
API source questions are on-topic and compounders dodging them is newsworthy
Disagree on that part. 96.8% and 96.2% on the same vial is normal.
Respectfully this is a sample of one presented as a finding.
- 1Mechanistically the bit that matters is 503A. It explains most of the early…5 comments in this branch · started by u/clara_danquah
- 2the 503A/503B distinction is load-bearing, do not blur it5 comments in this branch · started by u/bruno_dumitru